HBK Investments’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,191	Closed	-$316K	–	886
2014 Q1	$316K	Buy	+1,191	New	+$316K	0.01%	727
2013 Q3	–	Sell	-7,467	Closed	-$1.75M	–	832
2013 Q2	$1.75M	Buy	+7,467	New	+$1.75M	0.03%	268